Literature DB >> 15188491

Review of cytokine profiles in patients with hepatitis.

Qiao-Ling Sun1, Wei Ran.   

Abstract

The development of T helper 1 versus T helper 2 cells is a major branch point in the immune response and is an important determinant of the body's response to an infectious pathogen, leading to protection of the host or dissemination of the disease. Recent studies have shown that there exist macrophage activation states in parallel to the T helper cell type 1/2 paradigm, and the T helper 1 development process is governed to a great degree by cytokine IL-12 provided mainly by antigen presenting cells such as macrophages and dendritic cells. A model in patients with hepatitis is proposed that links the pathogen, macrophage activation and T helper cell polarization.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15188491      PMCID： PMC4572254          DOI： 10.3748/wjg.v10.i12.1709

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  90 in total

1.  Effect of WF10 (TCDO) on antigen presentation.

Authors:  M S McGrath; C Benike; F W Kuehne; E Engleman
Journal:  Transplant Proc       Date:  1998-12       Impact factor: 1.066

2.  Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines.

Authors:  L P Erwig; K Stewart; A J Rees
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice.

Authors:  D R Milich; S F Wolf; J L Hughes; J E Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

Review 4.  Modulation of macrophage maturation by cytokines and lipid mediators: a potential role in resolution of pulmonary inflammation.

Authors:  P M Henson; D W Riches
Journal:  Ann N Y Acad Sci       Date:  1994-05-28       Impact factor: 5.691

5.  Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C.

Authors:  A Tran; G Yang; A Doglio; M Ticchioni; C Laffont; J Durant; J L Bernard; J Gugenheim; M C Saint-Paul; A Bernard; P Rampal; S Benzaken
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

6.  Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.

Authors:  Jayaprakash Sreenarasimhaiah; Andrés Jaramillo; Jeffrey Crippin; Mauricio Lisker-Melman; William C Chapman; T Mohanakumar
Journal:  Hum Immunol       Date:  2003-02       Impact factor: 2.850

7.  Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection.

Authors:  Heidi Barth; Reinhild Klein; Peter A Berg; Bertram Wiedenmann; Uwe Hopf; Thomas Berg
Journal:  Hepatogastroenterology       Date:  2003 Jan-Feb

8.  Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response.

Authors:  B Saha; G Das; H Vohra; N K Ganguly; G C Mishra
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

9.  Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.

Authors:  X G Fan; W E Liu; C Z Li; Z C Wang; L X Luo; D M Tan; G L Hu; Z Zhang
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

10.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.

Authors:  K Ando; T Moriyama; L G Guidotti; S Wirth; R D Schreiber; H J Schlicht; S N Huang; F V Chisari
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307
View more
  5 in total

1.  Is interleukin-8 an additional to histopathological changes diagnostic marker in HCV-infected patients with cryoglobulinemia?

Authors:  Joanna Cielecka-Kuszyk; Joanna Siennicka; Joanna Jabłońska; Olga Rek; Paulina Godzik; Daniel Rabczenko; Kazimierz Madaliński
Journal:  Hepatol Int       Date:  2011-03-20       Impact factor: 6.047

2.  Interferon-γ polymorphism and hepatocellular carcinoma susceptibility: a meta analysis.

Authors:  Jing Sun; Kai Liao; Yuefei Wang; Leida Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

4.  An Herbal Formula CGplus Ameliorates Stress-Induced Hepatic Injury in a BALB/c Mouse Model.

Authors:  Hyeong-Geug Kim; Yun-Hee Kim; Sung-Bae Lee; Jin-Seok Lee; Sung-Wook Chae; Dong-Gu Kim; Chang-Gue Son
Journal:  Front Pharmacol       Date:  2020-04-14       Impact factor: 5.810

5.  Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients.

Authors:  Chandra Chiappin Cardoso; Camila Matiollo; Carolina Hilgert Jacobsen Pereira; Janaina Santana Fonseca; Helder Emmanuel Leite Alves; Otavio Marcos da Silva; Vivian de Souza Menegassi; Claudia Regina Dos Santos; Ana Carolina Rabello de Moraes; Leonardo de Lucca Schiavon; Maria Claudia Santos-Silva
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.